BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

E. Boven, M. Verschraagen, T. M. Hulscher, C. A M Erkelens, F. H. Hausheer, H. M. Pinedo, W. J F Van der Vijgh

Research output: Contribution to journalArticlepeer-review

Abstract

BNP7787 (2′,2′-dithio-bis-ethane sulphonate sodium), a water-soluble disulphide, is chemically and mechanistically different from other sulphur-containing chemoprotective agents. Presently, BNP7787 is under investigation for its protective properties with regard to the side-effects of platinum compounds. In this study, we evaluated BNP7787, mesna and amifostine for their effects on the antitumour activity of platinum compounds. Continuous exposure to BNP7787 did not affect the antiproliferative effects of cisplatin or carboplatin, but the efficacy of both compounds was reduced in the presence of mesna in vitro in two human ovarian cancer cell lines. BNP7787 or amifostine combined with cisplatin or carboplatin given in standard schedules for the treatment of nude mice bearing well-established OVCAR-3 xenografts did not interfere with platinum-induced inhibition of tumour growth. Of interest, BNP7787 or amifostine co-administered with carboplatin was significantly more effective than carboplatin alone (P5-60 value of mesna 9-fold lower than that calculated after an equivalent dose of mesna by weight. We can conclude that BNP7787 does not interfere with the antitumour activity of platinum compounds in vitro and in vivo. Clinical trials are underway to evaluate the protection of normal tissues by BNP7787 when combined with cisplatin.

Original languageEnglish (US)
Pages (from-to)1148-1156
Number of pages9
JournalEuropean Journal of Cancer
Volume38
Issue number8
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Amifostine
  • BNP7787
  • Carboplatin
  • Cisplatin
  • Mesna
  • Nephrotoxicity

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts'. Together they form a unique fingerprint.

Cite this